Financials

  • Market Capitalization 3.37 B
  • Employee 227
  • Founded 2021
  • CEO N/A
  • Website www.alumis.com
  • Headquarter Delaware, United States
  • FIGI BBG01J7X4PN2
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-12.38
Relación precio/flujo de caja
241.45

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1612
ADPT
Adaptive Biotechnologies Corporation - Common Stock
21.43 USD+1.95%+6.25%+32.61%+24.16%3.43 B USD
1616
DYN
Dyne Therapeutics, Inc. - Common Stock
23.78 USD+0.59%+1.62%+26.96%+1.58%3.40 B USD
1629
ARQT
Arcutis Biotherapeutics, Inc. - Common stock
26.81 USD-1.14%-2.05%+4.44%+72.41%3.35 B USD
1657
IDYA
IDEAYA Biosciences, Inc. - Common Stock
36.65 USD+1.38%-7.94%+21.20%+12.49%3.22 B USD